Search results
Avidity Biosciences, Inc. (RNA) Expected to Beat Earnings Estimates: What to Know Ahead of Q2...
Zacks via Yahoo Finance· 2 years agoAvidity Biosciences, Inc. (RNA) possesses the right combination of the two key ingredients for a...
Avidity Biosciences, Inc. (RNA) Reports Q4 Loss, Misses Revenue Estimates
Zacks via Yahoo Finance· 3 months agoAvidity Biosciences, Inc. (RNA) delivered earnings and revenue surprises of -46.30% and 93.17%,...
Avidity Biosciences (NASDAQ:RNA) Is In A Good Position To Deliver On Growth Plans
Simply Wall St. via Yahoo Finance· 1 year agoThere's no doubt that money can be made by owning shares of unprofitable businesses. For example,...
Insider Sell: Avidity Biosciences Inc (RNA) President and CEO Sarah Boyce Sells 28,000 Shares
GuruFocus.com via Yahoo Finance· 2 months agoPresident and CEO Sarah Boyce of Avidity Biosciences Inc (NASDAQ:RNA) sold 28,000 shares of the...
Avidity (RNA) Down on Update From Neuromuscular Disease Study
Zacks via Yahoo Finance· 1 year agoAvidity Biosciences (RNA) provides an update on its phase I/II study of its lead product candidate...
What Makes Avidity Biosciences, Inc. (RNA) a New Buy Stock
Zacks via Yahoo Finance· 2 years agoAvidity Biosciences, Inc. (RNA) might move higher on growing optimism about its earnings prospects,...
Avidity (RNA) Down on Partial Hold of Myotonic Dystrophy Study
Zacks via Yahoo Finance· 2 years agoAvidity Biosciences (RNA) reports FDA-imposed partial hold on enrolling new patients in its phase...
Shareholders in Avidity Biosciences (NASDAQ:RNA) are in the red if they invested a year ago
Simply Wall St. via Yahoo Finance· 2 years agoOver the last month the Avidity Biosciences, Inc. (NASDAQ:RNA) has been much stronger than before,...
Following a 16% decline over last year, recent gains may please Avidity Biosciences, Inc....
Simply Wall St. via Yahoo Finance· 1 year agoIf you want to know who really controls Avidity Biosciences, Inc. (NASDAQ:RNA), then you'll have to...
Avidity (RNA) Expands Collaboration With BMY, Shares Rise
Zacks via Yahoo Finance· 6 months agoShares of Avidity Biosciences, Inc. RNA surged 14.9% following the expansion of its global licensing...